Follow us on:
Breaking News
August 24, 2026
Breaking News
Breaking News
Federal Equipment_CP_Leaderboard_8/24/26
Featured VideoBite from Contract Pharma
PLD_VideoBite_0626_FeaturedSpotlight

Werewolf, Ambros to Merge in All-Stock Deal

 
Werewolf, Ambros to Merge in All-Stock Deal

Combined company will operate as Ambros Therapeutics and advance neridronate for CRPS-1.
Read More >>

Headlines

Breaking News
Promotions & Moves

AN2 Therapeutics Names Dr. Cameron Trenor as Chief Medical Officer

Trenor is a physician-scientist and biotechnology executive with 20+ years of experience leading clinical and translational development programs.

SPONSOR

The CGT Supply Chain Starts With Better Plasmid Manufacturing

Yield, purity, scalability. Learn how to optimize every stage of plasmid production for cell and gene therapy. Free webinar, August 27.

Breaking News
Collaborations & Alliances

Alvotech, Lotus Ink Biosimilar Licensing and Commercialization Pact in US, Asia

The agreement covers eight select Asian markets.

Breaking News

Ashland Launches Permexa Sodium Caprate High-Performance Intestinal Permeation Enhancer

This supports scalable development and commercialization of oral peptide, biologic, and low-permeability drug products.

SPONSOR

Tailored CDMO Support That Reduces Risk and Delays

No two injectables are alike. Learn how flexible CDMO partnerships cut risk, speed timelines, and protect product integrity from vial to patient.

AAPS_CP_Box Ad_0826

Breaking News
Promotions & Moves

Barentz Appoints Matt Mitchell as Global VP, Pharmaceuticals

Mitchell brings 25+ years of experience in the specialty ingredients industry.

Featured Resources

Solution Content Center SPOTLIGHT

Sofgen CDMO

Sofgen Pharma is a leading integrated healthcare and pharmaceutical company that develops and manufactures pharmaceutical and nutraceutical solutions. They have a direct presence in 13 countries - Bolivia, Brazil, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Peru, and United States with customers located in over 50 countries.

 

Solution Center SPOTLIGHT

Quotient Sciences

Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway, from candidate selection through commercial manufacturing. We offer global services for drug substance synthesis and manufacturing, formulation development, clinical trials and clinical & commercial manufacturing.